{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:22Z","timestamp":1787020822328,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Research and Graduate Studies at King Khalid University","award":["RGP2\/399\/45"],"award-info":[{"award-number":["RGP2\/399\/45"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01528-9","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:25:19Z","timestamp":1748834719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals"],"prefix":"10.1186","volume":"19","author":[{"given":"Adil","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrhman","family":"Alsayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Almrasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"2","key":"1528_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","volume":"14","author":"AP Thrift","year":"2017","unstructured":"Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017;14(2):122\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1528_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.10.009","volume":"183","author":"U Spengler","year":"2018","unstructured":"Spengler U. Direct antiviral agents (DAAs)\u2014a new age in the treatment of hepatitis C virus infection. Pharmacol Ther. 2018;183:118\u201326.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1528_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1586\/17512433.2016.1129272","volume":"9","author":"SM McConachie","year":"2016","unstructured":"McConachie SM, Wilhelm SM, Kale-Pradhan PB. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir. Expert Rev Clin Pharmacol. 2016;9(2):287\u2013302.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1528_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1478-3231.2010.02411.x","volume":"31","author":"T Asselah","year":"2011","unstructured":"Asselah T, Marcellin P. New direct-acting antivirals\u2019 combination for the treatment of chronic hepatitis C. Liver Int. 2011;31:68\u201377.","journal-title":"Liver Int"},{"issue":"4","key":"1528_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3748\/wjg.v22.i4.1421","volume":"22","author":"R Gonz\u00e1lez-Grande","year":"2016","unstructured":"Gonz\u00e1lez-Grande R, Jim\u00e9nez-P\u00e9rez M, Arjona CG, Torres JM. New approaches in the treatment of hepatitis C. World J Gastroenterol. 2016;22(4):1421.","journal-title":"World J Gastroenterol"},{"key":"1528_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11904-013-0182-8","volume":"10","author":"CA Chastain","year":"2013","unstructured":"Chastain CA, Naggie S. Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014. Curr HIV\/AIDS Rep. 2013;10:408\u201319.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"1528_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5604\/16652681.1231577","volume":"16","author":"MS Rezaee-Zavareh","year":"2017","unstructured":"Rezaee-Zavareh MS, Hesamizadeh K, Behnava B, Alavian SM, Gholami-Fesharaki M, Sharafi H. Combination of ledipasvir and sofosbuvir for treatment of hepatitis C virus genotype 1 infection: systematic review and meta-analysis. Ann Hepatol. 2017;16(2):188\u201397.","journal-title":"Ann Hepatol"},{"key":"1528_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20902\/IJCTR.2019.120305","volume":"12","author":"MS Kishore","year":"2019","unstructured":"Kishore MS, Rambabu C. Development and Validation of UV Spectrophotometric method for the estimation of Sofosbuvir and Ledipasvir in combined pharmaceutical dosage forms. Int J ChemTech Res. 2019;12:33\u201340.","journal-title":"Int J ChemTech Res"},{"key":"1528_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.104372","volume":"152","author":"BS Mohammed","year":"2020","unstructured":"Mohammed BS, Hamad AE, El-Malla SF, Derayea SM. Sensitive spectrofluorimetric assay based on micelle enhanced protocol for the determination of hepatitis C antiviral agent (simeprevir): application to dosage form and human plasma. Microchem J. 2020;152: 104372.","journal-title":"Microchem J"},{"issue":"2","key":"1528_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/bio.3425","volume":"33","author":"KA Attia","year":"2018","unstructured":"Attia KA, El-Abasawi NM, El-Olemy A, Serag A. Simeprevir oxidative degradation product: molecular modeling, in silico toxicity and resolution by synchronous spectrofluorimetry. Luminescence. 2018;33(2):382\u201390.","journal-title":"Luminescence"},{"key":"1528_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.118471","volume":"239","author":"AE Hamad","year":"2020","unstructured":"Hamad AE, Mohammed BS, Derayea SM, El-Malla SF. Micelle sensitized synchronous spectrofluorimetric approaches for the simultaneous determination of simeprevir and ledipasvir: application to pharmaceutical formulations and human plasma. Spectrochim Acta Part A Mol Biomol Spectrosc. 2020;239: 118471.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"4","key":"1528_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/bio.3753","volume":"35","author":"MA Abdel-Lateef","year":"2020","unstructured":"Abdel-Lateef MA, Ali R, Omar MA, Derayea SM. Micellar-based spectrofluorimetric method for the selective determination of ledipasvir in the presence of sofosbuvir: application to dosage forms and human plasma. Luminescence. 2020;35(4):486\u201392.","journal-title":"Luminescence"},{"key":"1528_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2020.105251","volume":"158","author":"HI El-Shorbagy","year":"2020","unstructured":"El-Shorbagy HI, Elsebaei F, Hammad SF, El-Brashy AM. A green stability-indicating RP-HPLC-UV method using factorial design for determination of ribavirin, sofosbuvir and ledipasvir: Application to average content, acid degradation kinetics and in vitro drug interactions study. Microchem J. 2020;158: 105251.","journal-title":"Microchem J"},{"issue":"1","key":"1528_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40543-019-0197-x","volume":"10","author":"A Hemdan","year":"2019","unstructured":"Hemdan A, Eissa MS. Simultaneous chromatographic analysis of Sofosbuvir\/Ledipasvir in their combined dosage form: an application to green analytical chemistry. J Anal Sci Technol. 2019;10(1):39.","journal-title":"J Anal Sci Technol"},{"issue":"1","key":"1528_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/22297928.2017.1287004","volume":"7","author":"KA Attia","year":"2017","unstructured":"Attia KA, El-Abasawi NM, El-Olemy A, Serag A. Stability-indicating HPLC-DAD method for the determination of Simeprevir. Anal Chem Lett. 2017;7(1):43\u201351.","journal-title":"Anal Chem Lett"},{"key":"1528_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jpba.2016.04.031","volume":"125","author":"A Ariaudo","year":"2016","unstructured":"Ariaudo A, Favata F, De Nicol\u00f2 A, Simiele M, Paglietti L, Boglione L, Cardellino CS, Carcieri C, Di Perri G, D\u2019Avolio A. A UHPLC\u2013MS\/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir\/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. J Pharm Biomed Anal. 2016;125:369\u201375.","journal-title":"J Pharm Biomed Anal"},{"key":"1528_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jchromb.2019.01.024","volume":"1110","author":"M van Seyen","year":"2019","unstructured":"van Seyen M, de Graaff Teulen MJ, van Erp NP, Burger DM. Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS\/MS. J Chromatography B. 2019;1110:15\u201324.","journal-title":"J Chromatography B"},{"key":"1528_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.saa.2015.10.040","volume":"154","author":"KAM Attia","year":"2016","unstructured":"Attia KAM, Nassar MWI, El-Zeiny MB, Serag A. Zero order and signal processing spectrophotometric techniques applied for resolving interference of metronidazole with ciprofloxacin in their pharmaceutical dosage form. Spectrochim Acta Part A Mol Biomol Spectrosc. 2016;154:232\u20136.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1528_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.saa.2016.01.056","volume":"159","author":"KAM Attia","year":"2016","unstructured":"Attia KAM, Nassar MWI, El-Zeiny MB, Serag A. Stability-indicating methods for the analysis of ciprofloxacin in the presence of its acid induced degradation product: a comparative study. Spectrochim Acta Part A Mol Biomol Spectrosc. 2016;159:219\u201322.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"issue":"1","key":"1528_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13065-024-01286-0","volume":"18","author":"A Alqahtani","year":"2024","unstructured":"Alqahtani A, Alqahtani T, Al Fatease A, Tolba EH. Rapid UV-Vis spectrophotometric method aided by firefly-PLS models for the simultaneous quantification of ciprofloxacin, lomefloxacin, and enrofloxacin in their laboratory mixture, dosage forms and water samples: greenness and blueness assessment. BMC Chem. 2024;18(1):172.","journal-title":"BMC Chem"},{"key":"1528_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.119042","volume":"246","author":"MB El-Zeiny","year":"2021","unstructured":"El-Zeiny MB, Zawbaa HM, Serag A. An evaluation of different bio-inspired feature selection techniques on multivariate calibration models in spectroscopy. Spectrochim Acta Part A Mol Biomol Spectrosc. 2021;246: 119042.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1528_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120334","volume":"264","author":"A Serag","year":"2022","unstructured":"Serag A, Hasan MA, Tolba EH, Abdelzaher AM, Elmaaty AA. Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools. Spectrochim Acta Part A Mol Biomol Spectrosc. 2022;264: 120334.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1528_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.123710","volume":"308","author":"A Alqahtani","year":"2024","unstructured":"Alqahtani A, Abdelazim AH, Alqahtani T, Gahtani RM, Serag A. Augmented least squares, a powerful chemometric approach for the spectroscopic analysis of the antiretroviral therapy abacavir, lamivudine and dolutegravir in their ternary mixture. Spectrochim Acta Part A Mol Biomol Spectrosc. 2024;308: 123710.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"1528_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2024.100108","volume":"9","author":"S Yenduri","year":"2024","unstructured":"Yenduri S, Koppuravuri NP, Varalakshmi HN. Assessment and comparison of sustainability aspects of UV-spectroscopy methods for simultaneous determination of anti-hypertensive combination. Green Anal Chem. 2024;9: 100108.","journal-title":"Green Anal Chem"},{"issue":"14","key":"1528_CR25","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014analytical GREEnness metric approach and software. Anal Chem. 2020;92(14):10076\u201382.","journal-title":"Anal Chem"},{"issue":"3","key":"1528_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/analytica5030030","volume":"5","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, P\u0142otka-Wasylka J, Locatelli M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications. Analytica. 2024;5(3):451\u20137.","journal-title":"Analytica"},{"issue":"19","key":"1528_CR27","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi N, Wojnowski W, P\u0142otka-Wasylka J, Samanidou V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 2023;25(19):7598\u2013604.","journal-title":"Green Chem"},{"key":"1528_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223","volume":"138","author":"PM Nowak","year":"2021","unstructured":"Nowak PM, Wietecha-Pos\u0142uszny R, Pawliszyn J. White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality. TrAC, Trends Anal Chem. 2021;138: 116223.","journal-title":"TrAC, Trends Anal Chem"},{"issue":"12","key":"1528_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cem.3190","volume":"33","author":"MA Hegazy","year":"2019","unstructured":"Hegazy MA, Abdelwahab NS, Ali NW, Sharkawi MMZ, Abdelkawy MM, El-Saadi MT. Comparison of two augmented classical least squares algorithms and PLS for determining nifuroxazide and its genotoxic impurities using UV spectroscopy. J Chemom. 2019;33(12): e3190.","journal-title":"J Chemom"},{"issue":"13","key":"1528_CR30","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1021\/ac800155n","volume":"80","author":"W Saeys","year":"2008","unstructured":"Saeys W, Beullens K, Lammertyn J, Ramon H, Naes T. Increasing robustness against changes in the interferent structure by incorporating prior information in the augmented classical least-squares framework. Anal Chem. 2008;80(13):4951\u20139.","journal-title":"Anal Chem"},{"issue":"5","key":"1528_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1366\/0003702021955178","volume":"56","author":"DK Melgaard","year":"2002","unstructured":"Melgaard DK, Haaland DM, Wehlburg CM. Concentration residual augmented classical least squares (CRACLS): a multivariate calibration method with advantages over partial least squares. Appl Spectrosc. 2002;56(5):615\u201324.","journal-title":"Appl Spectrosc"},{"issue":"1","key":"1528_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0924-2031(01)00199-0","volume":"29","author":"DM Haaland","year":"2002","unstructured":"Haaland DM, Melgaard DK. New augmented classical least squares methods for improved quantitative spectral analyses. Vib Spectrosc. 2002;29(1):171\u20135.","journal-title":"Vib Spectrosc"},{"issue":"2","key":"1528_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bfopcu.2011.10.001","volume":"49","author":"IA Naguib","year":"2011","unstructured":"Naguib IA. Stability indicating analysis of bisacodyl by partial least squares regression, spectral residual augmented classical least squares and support vector regression chemometric models: a comparative study. Bull Faculty Pharm Cairo University. 2011;49(2):91\u2013100.","journal-title":"Bull Faculty Pharm Cairo University"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01528-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01528-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:25:20Z","timestamp":1748834720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01528-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01528-9","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Not applicable to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication:"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}